Physician profile
Sanjeev P Bhavnani
NPI 1578740098
$29,426.09
in general payments reported to CMS, 2019-2025
17 companies · $63.25 in 2025
The $63.25 reported for 2025 was less than what a typical Nuclear Cardiology provider received nationally (typical 2025 total: $434).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,376 · 2020: $11K · 2021: $6,781 · 2022: $130 · 2023: $21.72 · 2024: $6,959 · 2025: $63.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,285 · Travel and Lodging: $1,233 · Food and Beverage: $526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,285.00 |
| Travel and Lodging | $1,232.58 |
| Food and Beverage | $526.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $16,801.85 | 2019-2024 | Eliquis, Camzyos |
| Pfizer INC. | $11,648.82 | 2019-2022 | |
| Braemar Manufacturing, LLC | $217.21 | 2019 | |
| Abbott Laboratories | $159.73 | 2019 | |
| Novartis Pharmaceuticals Corporation | $155.63 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.78 | 2020-2022 | |
| Kiniksa Pharmaceuticals, Ltd. | $68.02 | 2021-2022 | |
| Irhythm Technologies, INC. | $60.93 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| Astrazeneca Pharmaceuticals Lp | $49.00 | 2021 | |
| Merck Sharp & Dohme LLC | $43.08 | 2022 | |
| Medtronic, INC. | $30.31 | 2022 | |
| Akcea Therapeutics, INC. | $23.84 | 2020 | |
| Cvrx, INC. | $21.72 | 2023 | Barostim Neo System |
| Boston Scientific Corporation | $19.44 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.71 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $16.55 | 2021 | |
| Baxter Healthcare | $15.47 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjeev Bhavnani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.